The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A)
Clinical trial NCT05361031 · COMPLETED
Trial details
- NCT number
- NCT05361031
- Sponsor
- Helixmith Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2021-09-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.